Specific immunotherapy in the complex treatment of ovarian cancer

Cover Page


Cite item

Full Text

Abstract

The article is devoted to the search for new solutions in the field of treatment of malignant ovarian tumors and, in particular, new approaches for overcoming immune resistance in a complex method of therapy. The experience of treating this pathology with an original method of postoperative immunotherapy using autologous immunomodulators, which, due to its simplicity and relatively low cost, should be widely used in gynecological oncology, is considered.

About the authors

O. V. Makarov

Russian State Medical University

Email: info@eco-vector.com
Russian Federation, Moscow

A. A. Krotenko

Russian State Medical UniversityА.А. Кротенко

Email: info@eco-vector.com
Russian Federation, Moscow

V. N. Kosetsky

Russian State Medical University

Email: info@eco-vector.com
Russian Federation, Moscow

I. G. Sidorovich

Russian State Medical University

Email: info@eco-vector.com
Russian Federation, Moscow

V. I. Novikov

Russian State Medical University

Email: info@eco-vector.com
Russian Federation, Moscow

A. A. Vlasov

Russian State Medical University

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Moscow

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Eсо-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).